Medical and Scientific Research

Invest SVG > Data > Medical and Scientific Research

Medical and Scientific Research

St. Vincent & The Grenadines has now completed legislation for the commencement of a Medical Cannabis Industry, which is being spearheaded by the Medicinal Cannabis Authority of St. Vincent and the Grenadines.

The industry has the potential to positively transform rural livelihoods and communities while changing the lives of patients who suffer from medical conditions that are unresponsive to other treatments.

Additionally, the availability of rich volcanic soils and a warm tropical climate in SVG presents the perfect opportunity for growing, thus also for cannabis investment.

MEDICAL INNOVATIONS FROM CANNABIS UNDERAPPRECIATED BENEFIT: COST SAVINGS

The incalculable billions of dollars in savings to patients using cannabis derived treatments to their families, insurers, employers, governments and hospitals in avoided medical expenses associated with keeping people healthy or curing them of serious, life-threatening, life-long or chronic conditions is a hallmark of the Medical Cannabis Association (MCA).

By finding new treatments, people no longer need to seek or spend extensive sums on treatment. This offers better care management and the possibility to prevent more serious complications from existing medical issues, as people can avoid more costly and/or risk-intensive medical care.

Top 30+ reasons to invest in our Cannabis Industry

Tropical climate ideal for extra low-cost ‘outdoor’ cannabis production.
Over 50 years of experience in cannabis cultivation.
More than 2000 traditional cannabis farmers.
Decades of experience in high-quality agriculture commercial production and export.
Availability of arable lands.
Rich volcanic soil suitable for producing high quality agriculture products
International air and sea port connections.
Significant investment in education thus creating a working age population that is ready to embrace and support development of this type.
Highly trained workers in modern agricultural technology.
365 days of efficient water supply.
An exotic tourism location, with 32 islands and cays, and over a quarter million cruise ship passenger visits forecasted for 2019.
Multimillion-dollar state investments in green energy:
10-Megawatt Geothermal Plant
Solar Energy
Hydro Energy.
Experience in certification of Fairtrade, HACCP, ISO’s, Global GAP and EurepGAP existing.
Certification in GMP, FSMA, BRC, GPP and GAP by May 2019.
Movement toward 100% organic production in agriculture, which begun with a total ban on all glyphosate products including ‘Round Up’, Glyphos and ‘Touchdown.’
A stable Investment environment.
Stable currency: Eastern Caribbean dollar pegged to the USD.

Commitment to the Sustainable Development Goals of the United Nations.
Unique strains of domestically produced Cannabis available for scientific research and development.
A history of, and continuous full compliance will all International narcotics treaties and conventions.
Simple guidelines for licensing, monitoring, production and export.
Well-crafted legislation aimed at providing full accountability: unique opportunities for investment and draws on recent changes in the global cannabis industry.
Fiscal incentives to reduce startup cost for investors.
Well-staffed and trained ‘Modern Cannabis Authority’ to ensure effective / efficient regulations.
Opportunities to invest in other non-cannabis sectors such as tropical agriculture, tourism and other emerging markets.
Medicinal cannabis healthcare products and services would be accessible in SVG.
Cannabis is likely to be VAT exempted since it is an agricultural commodity.
An established national bio-pesticide, bio-fertilizer production platform to support organic cannabis production.
At least 10% of all cannabis raw material for processing must be bought from traditional farmers.
St. Vincent and the Grenadines maintains a politically stable environment.

Learn more Now: Go to the MCA website

Medical Cannabis Authority Board Information

The Medicinal Cannabis Authority is governed by a Board of Directors, established under the framework of the Medicinal Cannabis Industry Act, 2018. This Board is responsible for the policy, strategic direction and governance of the Authority. The Board comprises senior representatives from ministries and statutory bodies that are integral to the mandate of the authority:

Agriculture	Legal Affairs
Finance	National Investment Promotion Agency (InvestSVG)
Health	Bureau of Standards
National Security	Land and Surveys

Included in the Board composition are also professionals from the private sector who possess specialist knowledge and experience essential to the strategic positioning of the Authority including medicine, law, engineering, scientific research, business, land development and agriculture. The Chairman of the Advisory Council on the Misuse of Drug, established under the Drugs (Prevention and Misuse) Act sits on the Board of Directors to provide guidance on matters relevant to his expertise.

Key Functions

Develop policies, procedures and guidelines to ensure that medicinal cannabis is available to patients in a safe and efficient manner;
Regulate the cultivation, supply, possession and use of medicinal cannabis;
Review medical certificates submitted by medical doctors on behalf of a patient in accordance with the Act;
Issue licences and other authorisations in relation to the cultivation, supply, use and possession of medicinal cannabis in accordance with the provisions of the Act and Regulations made pursuant to the Act;
Develop enforcement procedures in relation to the inspection of premises that are operated by licensees in order to ensure compliance with the provisions of the Act or any Regulations made pursuant to the Act;
Register patients and caregivers accordingly;
Establish and maintain an electronic database to include information relating to patients, medical doctors, licensees, medical certificates and identification cards and to provide for the electronic tracking of the cultivation, supply, possession and use of medicinal cannabis in accordance with this Act or Regulations made pursuant to the Act;
Establish and maintain a confidential register of patients; and
Provide for the distribution of educational materials and conduct training programmes in relation to the development of medicinal cannabis